A novel dark antigen class
We believe camyotopes are a game changing set of tumor targets with unparalleled potential for therapeutic cancer vaccine development.
Specific translation in cancer
Very high abundance within patients
Unlocking first-in-class targets from the under-exploited dark genome.
More than 95% target population coverage
Subscribe to our newsletter
Get the latest news & updates about myNEO Therapeutics